Chime Biologics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 900

Employees

  • Latest Deal Type
  • Series B1

  • Investors
  • 4

Chime Biologics General Information

Description

Developer and manufacturer of biological products designed to provide customers with a one-stop biopharmaceutical chemistry, manufacturing and controls (CMC) solution. The company offers omclude water injection, freeze drying and pre-filling medicine and supports early drug development to late clinical research and commercial cGMP production to meet the dynamic needs of the biopharmaceutical industry, thereby providing patients with affordable medicine options and improved level of treatment.

Contact Information

Formerly Known As
Xikang (Wuhan) Biopharmaceutical Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 388, Gaoxin 2nd Road
  • East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Number 388, Gaoxin 2nd Road
  • East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027

Chime Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chime Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 16-Dec-2025 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Feb-2023 Completed Generating Revenue
2. Later Stage VC (Series A1) 26-Mar-2021 $190M $315M Completed Generating Revenue
1. Later Stage VC (Series A) 10-Mar-2020 $125M $125M Completed Generating Revenue
To view Chime Biologics’s complete valuation and funding history, request access »

Chime Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of biological products designed to provide customers with a one-stop biopharmaceutical chemis
Other Pharmaceuticals and Biotechnology
Wuhan, China
900 As of 2026

Kaiseraugst, Switzerland
 

Beijing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chime Biologics Competitors (49)

One of Chime Biologics’s 49 competitors is Solvias, a Private Equity-Backed company based in Kaiseraugst, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solvias Private Equity-Backed Kaiseraugst, Switzerland
Bellen Chemistry Venture Capital-Backed Beijing, China
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
MabPlex Venture Capital-Backed Yantai, China
JOINN Biologics Venture Capital-Backed Beijing, China
You’re viewing 5 of 49 competitors. Get the full list »

Chime Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chime Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fidelity International Asset Manager Minority
Panacea Capital (California) Venture Capital Minority
VMS Group (Hong Kong) Growth/Expansion Minority
Biomark Capital PE/Buyout Minority
To view Chime Biologics’s complete investors history, request access »

Chime Biologics Investments (1)

Chime Biologics’s most recent deal was a Later Stage VC with Sumgen. The deal was made on 25-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sumgen 25-Dec-2025 Later Stage VC Drug Discovery
To view Chime Biologics’s complete investments history, request access »

Chime Biologics FAQs

  • When was Chime Biologics founded?

    Chime Biologics was founded in 2013.

  • Where is Chime Biologics headquartered?

    Chime Biologics is headquartered in Wuhan, China.

  • What is the size of Chime Biologics?

    Chime Biologics has 900 total employees.

  • What industry is Chime Biologics in?

    Chime Biologics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Chime Biologics a private or public company?

    Chime Biologics is a Private company.

  • What is Chime Biologics’s current revenue?

    The current revenue for Chime Biologics is .

  • How much funding has Chime Biologics raised over time?

    Chime Biologics has raised $332M.

  • Who are Chime Biologics’s investors?

    Fidelity International, Panacea Capital (California), VMS Group (Hong Kong), and Biomark Capital have invested in Chime Biologics.

  • Who are Chime Biologics’s competitors?

    Solvias, Bellen Chemistry, Charles River Laboratories International, MabPlex, and JOINN Biologics are some of the 49 competitors of Chime Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process